Shearman & Sterling represented Investcorp in connection with its agreement to acquire a majority interest in Cambio Healthcare Systems from Valedo Partners Fund II AB and a group of minority investors.
Investcorp has reached an agreement to acquire Cambio Healthcare Systems AB from Valedo Partners Fund II AB and a group of minority investors, primarily Cambio’s two founders, Tomas Mora-Morrison and Håkan Mattsson. Valedo invested in Cambio in 2012 and has, together with the Company’s management team and employees, transformed and significantly grown Cambio into a position as one of the leading regional European providers of eHealth solutions.
Cambio operates in the Electronic Health Records (“EHR”) market, offering software solutions for acute, primary, social and person-centred care. Cambio promotes a holistic view on health and social care and offers an EHR agnostic solution for clinical decision support applicable for all branches of health and social care. The Company, which has grown rapidly in recent years, has customers primarily in Sweden, Denmark and the United Kingdom, with more than 150,000 users of its software solutions. Cambio is headquartered in Stockholm, Sweden and has approximately 600 employees, of which the majority are dedicated to research and development as well as software maintenance.
Shearman & Sterling represented Investcorp on the deal with a team including Korey Fevzi (Picture), Jackson Lam and Hannah Drake.
Law Firms: Shearman & Sterling;